
Overview
Auxilius Pharma is an emerging pharmaceutical company focused on developing Value-Added Medicines for cardiovascular health, specifically targeting chronic stable angina. The company is introducing AUX-001, an effective angina symptom-controlling agent that is taken once daily and has shown to reduce hospitalization rates. AUX-001 utilizes the active ingredient nicorandil and aims to address both macro and microvascular angina.
Financials
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 5 days late). All were audited by a statutory auditor.
- 202520/07/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Cardiology medicines
- Anti-anginal medicines
- Modified-release nicorandil
Websites
- auxiliuspharma.comAuxilius PharmaGoogle AnalyticsGoogle Tag Manager
Authorized Representatives
Manner of representation
The company is represented by one member of the management board in the case of a one-person management board, and by two members of the management board acting jointly or by a member of the management board together with a commercial proxy in the case of a multi-member management board.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-03-30.
24 1020 4900 0000 8302 3843 2671
87 1050 1025 1000 0090 8439 9469
57 1020 4900 0000 8102 3843 2660
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 4, 2022 | Aid for SME access to finance — risk finance aid | $896.9K$896,932 | PFR Ventures sp. z o.o. |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-23 | Share capital increase (177,750.80 PLN → 178,547.90 PLN) | |
| 2025-07-28 | Address change (Hoża 46/810, 00-682, Warszawa → Ul. Hoża 86/410, 00-682, Warszawa) | |
| 2025-07-28 | Share capital increase (175,350.00 PLN → 177,750.80 PLN) | |
| 2025-04-03 | Entered in the register |
FAQ
Last updated: 2026-11-05